| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 86 | 2023 | 11725 | 3.550 |
Why?
|
| Diabetic Nephropathies | 24 | 2022 | 984 | 3.050 |
Why?
|
| Allopurinol | 5 | 2020 | 191 | 1.750 |
Why?
|
| Polymorphism, Single Nucleotide | 37 | 2022 | 15519 | 1.730 |
Why?
|
| Uric Acid | 8 | 2020 | 766 | 1.550 |
Why?
|
| Diabetic Angiopathies | 10 | 2018 | 818 | 1.520 |
Why?
|
| Diabetes Mellitus, Type 1 | 37 | 2021 | 3336 | 1.450 |
Why?
|
| Glomerular Filtration Rate | 18 | 2023 | 2170 | 1.450 |
Why?
|
| Coronary Disease | 8 | 2022 | 6077 | 1.230 |
Why?
|
| Fenofibrate | 4 | 2020 | 88 | 1.190 |
Why?
|
| Glutamate-Ammonia Ligase | 3 | 2020 | 74 | 1.150 |
Why?
|
| Hyperuricemia | 2 | 2018 | 211 | 0.830 |
Why?
|
| Gout Suppressants | 2 | 2020 | 166 | 0.810 |
Why?
|
| Xanthine Oxidase | 1 | 2020 | 64 | 0.740 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 2208 | 0.710 |
Why?
|
| Genetic Markers | 8 | 2018 | 2634 | 0.700 |
Why?
|
| Anemia, Megaloblastic | 1 | 2019 | 25 | 0.690 |
Why?
|
| Diabetes Mellitus | 8 | 2020 | 5751 | 0.680 |
Why?
|
| Haptoglobins | 1 | 2020 | 165 | 0.670 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2019 | 340 | 0.670 |
Why?
|
| Coronary Artery Disease | 11 | 2018 | 6487 | 0.660 |
Why?
|
| Genetic Predisposition to Disease | 28 | 2022 | 17446 | 0.660 |
Why?
|
| PPAR alpha | 1 | 2020 | 197 | 0.640 |
Why?
|
| Cardiovascular Diseases | 14 | 2023 | 15165 | 0.640 |
Why?
|
| Genotype | 29 | 2020 | 12951 | 0.600 |
Why?
|
| Insulin Resistance | 13 | 2015 | 3864 | 0.600 |
Why?
|
| Chromosomes, Human, Pair 9 | 3 | 2012 | 535 | 0.580 |
Why?
|
| Dyslipidemias | 3 | 2020 | 849 | 0.570 |
Why?
|
| Blood Glucose | 21 | 2022 | 6256 | 0.570 |
Why?
|
| Insulin Receptor Substrate Proteins | 6 | 2013 | 563 | 0.570 |
Why?
|
| Kidney Failure, Chronic | 8 | 2022 | 2538 | 0.570 |
Why?
|
| Hypolipidemic Agents | 2 | 2020 | 604 | 0.540 |
Why?
|
| Italy | 12 | 2015 | 832 | 0.540 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2020 | 658 | 0.540 |
Why?
|
| Insulin-Secreting Cells | 5 | 2020 | 891 | 0.530 |
Why?
|
| Insulin | 22 | 2022 | 6580 | 0.530 |
Why?
|
| Polymorphism, Genetic | 20 | 2013 | 4328 | 0.530 |
Why?
|
| Gene Frequency | 15 | 2022 | 3588 | 0.530 |
Why?
|
| Albuminuria | 13 | 2023 | 682 | 0.530 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 400 | 0.520 |
Why?
|
| Genetic Linkage | 11 | 2008 | 2421 | 0.520 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 2872 | 0.500 |
Why?
|
| Hemophilia A | 5 | 2012 | 351 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2007 | 403 | 0.470 |
Why?
|
| Diabetes Complications | 3 | 2011 | 1359 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2006 | 460 | 0.460 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1028 | 0.450 |
Why?
|
| Resistin | 5 | 2015 | 170 | 0.450 |
Why?
|
| Haplotypes | 8 | 2008 | 2779 | 0.430 |
Why?
|
| Chromosome Mapping | 10 | 2009 | 4740 | 0.430 |
Why?
|
| Age of Onset | 14 | 2020 | 3271 | 0.400 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2005 | 1676 | 0.400 |
Why?
|
| Humans | 171 | 2023 | 744343 | 0.390 |
Why?
|
| Cell Cycle Proteins | 7 | 2022 | 3462 | 0.390 |
Why?
|
| Adiponectin | 8 | 2013 | 1100 | 0.380 |
Why?
|
| Genetic Association Studies | 4 | 2018 | 2703 | 0.380 |
Why?
|
| Chromosomes, Human, Pair 12 | 3 | 2001 | 462 | 0.370 |
Why?
|
| Lod Score | 7 | 2007 | 614 | 0.350 |
Why?
|
| Hyperglycemia | 5 | 2022 | 1373 | 0.350 |
Why?
|
| Genetic Loci | 1 | 2019 | 2575 | 0.350 |
Why?
|
| Glutamine | 4 | 2023 | 578 | 0.350 |
Why?
|
| Glutamic Acid | 2 | 2023 | 1169 | 0.350 |
Why?
|
| Middle Aged | 72 | 2023 | 213383 | 0.340 |
Why?
|
| Losartan | 1 | 2011 | 299 | 0.340 |
Why?
|
| Pyrophosphatases | 5 | 2013 | 137 | 0.340 |
Why?
|
| Kidney | 13 | 2023 | 7186 | 0.340 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 3798 | 0.340 |
Why?
|
| Genetic Variation | 11 | 2014 | 6544 | 0.340 |
Why?
|
| Linkage Disequilibrium | 9 | 2011 | 1997 | 0.330 |
Why?
|
| Joint Diseases | 3 | 2012 | 480 | 0.330 |
Why?
|
| Phosphoric Diester Hydrolases | 5 | 2013 | 197 | 0.330 |
Why?
|
| Genes, Dominant | 6 | 2020 | 880 | 0.320 |
Why?
|
| Nuclear Proteins | 6 | 2007 | 5853 | 0.320 |
Why?
|
| Mutation | 14 | 2023 | 29786 | 0.320 |
Why?
|
| Receptors, Cell Surface | 3 | 2007 | 2866 | 0.320 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 451 | 0.320 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2008 | 66 | 0.310 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 1994 | 365 | 0.310 |
Why?
|
| Male | 99 | 2023 | 350118 | 0.310 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3479 | 0.310 |
Why?
|
| Cholesterol, HDL | 3 | 2012 | 1814 | 0.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2916 | 0.290 |
Why?
|
| Female | 94 | 2023 | 380194 | 0.290 |
Why?
|
| Cystatin C | 4 | 2023 | 250 | 0.280 |
Why?
|
| Genome-Wide Association Study | 10 | 2022 | 12261 | 0.280 |
Why?
|
| src-Family Kinases | 1 | 2009 | 551 | 0.280 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1995 | 768 | 0.280 |
Why?
|
| C-Reactive Protein | 3 | 2007 | 3778 | 0.280 |
Why?
|
| Models, Molecular | 2 | 2020 | 5456 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2004 | 299 | 0.270 |
Why?
|
| Receptors, Angiotensin | 2 | 1997 | 142 | 0.270 |
Why?
|
| Creatinine | 7 | 2023 | 1919 | 0.270 |
Why?
|
| Knee Joint | 3 | 2008 | 1680 | 0.270 |
Why?
|
| Mutation, Missense | 1 | 2015 | 2564 | 0.270 |
Why?
|
| Risk Factors | 28 | 2022 | 72290 | 0.270 |
Why?
|
| Case-Control Studies | 19 | 2022 | 21746 | 0.270 |
Why?
|
| Triglycerides | 4 | 2012 | 2454 | 0.260 |
Why?
|
| Receptor, Insulin | 7 | 2017 | 846 | 0.250 |
Why?
|
| Cation Transport Proteins | 1 | 2007 | 327 | 0.250 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 337 | 0.250 |
Why?
|
| Aged | 41 | 2023 | 163280 | 0.240 |
Why?
|
| Genome, Human | 5 | 2009 | 4420 | 0.240 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 2004 | 402 | 0.240 |
Why?
|
| Adult | 62 | 2023 | 214055 | 0.240 |
Why?
|
| Ankle Joint | 2 | 2008 | 411 | 0.230 |
Why?
|
| Alleles | 7 | 2019 | 6933 | 0.220 |
Why?
|
| Hormones, Ectopic | 1 | 2002 | 40 | 0.220 |
Why?
|
| Disease Progression | 11 | 2022 | 13284 | 0.220 |
Why?
|
| Fibrinogen | 1 | 2006 | 894 | 0.210 |
Why?
|
| Renin-Angiotensin System | 4 | 2020 | 759 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2019 | 326 | 0.210 |
Why?
|
| Glucose Intolerance | 3 | 2007 | 577 | 0.210 |
Why?
|
| Malate Dehydrogenase | 1 | 2022 | 41 | 0.210 |
Why?
|
| Uridine | 1 | 2022 | 146 | 0.210 |
Why?
|
| Odds Ratio | 13 | 2015 | 9849 | 0.200 |
Why?
|
| Aldehyde Reductase | 2 | 2017 | 65 | 0.200 |
Why?
|
| Centromere | 2 | 2017 | 220 | 0.200 |
Why?
|
| Reference Values | 16 | 2009 | 4982 | 0.190 |
Why?
|
| Pedigree | 6 | 2020 | 4644 | 0.190 |
Why?
|
| Pyruvaldehyde | 1 | 2020 | 21 | 0.190 |
Why?
|
| Transcription Factors | 6 | 2013 | 12208 | 0.190 |
Why?
|
| Base Sequence | 12 | 2006 | 12797 | 0.190 |
Why?
|
| Glucose | 13 | 2015 | 4397 | 0.190 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2013 | 86 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2915 | 0.180 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2001 | 233 | 0.180 |
Why?
|
| Hemarthrosis | 3 | 2012 | 38 | 0.180 |
Why?
|
| Models, Genetic | 3 | 2008 | 3494 | 0.180 |
Why?
|
| Obesity | 9 | 2015 | 12745 | 0.170 |
Why?
|
| Exons | 6 | 2015 | 2437 | 0.170 |
Why?
|
| Hemophilia B | 2 | 2012 | 81 | 0.170 |
Why?
|
| Heart Failure | 1 | 2023 | 10900 | 0.170 |
Why?
|
| DNA-Binding Proteins | 6 | 2007 | 9648 | 0.170 |
Why?
|
| ARNTL Transcription Factors | 1 | 2019 | 98 | 0.170 |
Why?
|
| Glutamates | 1 | 2020 | 398 | 0.170 |
Why?
|
| Kidney Function Tests | 4 | 2013 | 684 | 0.170 |
Why?
|
| Phenotype | 10 | 2022 | 16365 | 0.160 |
Why?
|
| Carboxypeptidases A | 1 | 2018 | 49 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1999 | 197 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2001 | 473 | 0.160 |
Why?
|
| Introns | 4 | 2007 | 991 | 0.160 |
Why?
|
| Ultrasonography, Doppler | 1 | 2000 | 458 | 0.160 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2019 | 72 | 0.160 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 4 | 2022 | 147 | 0.160 |
Why?
|
| Synovial Membrane | 1 | 2001 | 507 | 0.160 |
Why?
|
| Genetic Testing | 5 | 2023 | 3444 | 0.160 |
Why?
|
| Dipeptides | 1 | 2020 | 409 | 0.160 |
Why?
|
| Thiamine | 1 | 2019 | 152 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 3 | 2017 | 264 | 0.160 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2015 | 63 | 0.160 |
Why?
|
| beta Karyopherins | 1 | 2017 | 47 | 0.150 |
Why?
|
| Endophthalmitis | 1 | 2020 | 262 | 0.150 |
Why?
|
| Paracoccidioidomycosis | 1 | 1997 | 9 | 0.150 |
Why?
|
| Circadian Clocks | 1 | 2019 | 171 | 0.150 |
Why?
|
| Smad3 Protein | 1 | 2017 | 180 | 0.150 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1994 | 170 | 0.150 |
Why?
|
| Repressor Proteins | 4 | 2015 | 3023 | 0.140 |
Why?
|
| Ketone Bodies | 9 | 1992 | 82 | 0.140 |
Why?
|
| Cytokines | 2 | 2013 | 7322 | 0.140 |
Why?
|
| Cohort Studies | 12 | 2021 | 40561 | 0.140 |
Why?
|
| Adipose Tissue, Brown | 2 | 2015 | 757 | 0.140 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 804 | 0.140 |
Why?
|
| Risk | 5 | 2019 | 9687 | 0.140 |
Why?
|
| Molecular Sequence Data | 11 | 2004 | 18111 | 0.130 |
Why?
|
| Simvastatin | 1 | 2018 | 360 | 0.130 |
Why?
|
| Angiotensinogen | 1 | 1996 | 163 | 0.130 |
Why?
|
| Blood Pressure | 8 | 2020 | 8554 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 675 | 0.130 |
Why?
|
| Minisatellite Repeats | 1 | 1996 | 165 | 0.130 |
Why?
|
| Chemokines | 1 | 2020 | 970 | 0.130 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 320 | 0.130 |
Why?
|
| Adrenergic Agonists | 1 | 2015 | 58 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1996 | 417 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2022 | 1226 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2018 | 646 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2020 | 2618 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 393 | 0.120 |
Why?
|
| Serpins | 1 | 2015 | 247 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 601 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 3 | 2003 | 27 | 0.120 |
Why?
|
| Metabolomics | 1 | 2022 | 1484 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.120 |
Why?
|
| Acetanilides | 1 | 2015 | 168 | 0.110 |
Why?
|
| 5' Untranslated Regions | 2 | 2006 | 249 | 0.110 |
Why?
|
| DNA | 7 | 2017 | 7301 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 4751 | 0.110 |
Why?
|
| Body Mass Index | 7 | 2012 | 12720 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1995 | 354 | 0.110 |
Why?
|
| Atherosclerosis | 6 | 2014 | 3445 | 0.110 |
Why?
|
| Risk Assessment | 7 | 2019 | 23338 | 0.110 |
Why?
|
| Family Health | 2 | 2009 | 1282 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 3 | 2003 | 94 | 0.110 |
Why?
|
| Diabetic Retinopathy | 3 | 2011 | 1210 | 0.110 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2017 | 841 | 0.110 |
Why?
|
| Bone Diseases | 1 | 1997 | 416 | 0.110 |
Why?
|
| Proportional Hazards Models | 5 | 2023 | 12354 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 798 | 0.110 |
Why?
|
| Phosphoproteins | 2 | 1999 | 2440 | 0.110 |
Why?
|
| Autoantigens | 1 | 2017 | 892 | 0.110 |
Why?
|
| Signal Transduction | 9 | 2017 | 23403 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1993 | 367 | 0.110 |
Why?
|
| Boston | 5 | 2011 | 9313 | 0.110 |
Why?
|
| Sodium | 7 | 1995 | 1623 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1783 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2015 | 1682 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2015 | 2149 | 0.100 |
Why?
|
| Lipolysis | 1 | 2013 | 210 | 0.100 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 736 | 0.100 |
Why?
|
| Homozygote | 3 | 2007 | 1785 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2020 | 12026 | 0.100 |
Why?
|
| Lipids | 4 | 2020 | 3305 | 0.100 |
Why?
|
| Homeostasis | 3 | 2013 | 3340 | 0.100 |
Why?
|
| Inflammation | 3 | 2015 | 10638 | 0.100 |
Why?
|
| Myocardium | 3 | 2022 | 4776 | 0.100 |
Why?
|
| Metformin | 1 | 2018 | 835 | 0.100 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3505 | 0.100 |
Why?
|
| Off-Label Use | 1 | 2012 | 169 | 0.100 |
Why?
|
| Proteins | 2 | 2004 | 6103 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2008 | 2019 | 0.090 |
Why?
|
| Japan | 2 | 2006 | 1360 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 1912 | 0.090 |
Why?
|
| Prospective Studies | 9 | 2023 | 53288 | 0.090 |
Why?
|
| Receptors, Adiponectin | 2 | 2007 | 81 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2012 | 357 | 0.090 |
Why?
|
| Incidence | 5 | 2023 | 20947 | 0.090 |
Why?
|
| Lithium | 2 | 1992 | 601 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 1999 | 1184 | 0.080 |
Why?
|
| Cromolyn Sodium | 1 | 2009 | 87 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1889 | 0.080 |
Why?
|
| Animals | 18 | 2022 | 168757 | 0.080 |
Why?
|
| Thermogenesis | 1 | 2013 | 435 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2011 | 689 | 0.080 |
Why?
|
| Acetoacetates | 6 | 1990 | 22 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2022 | 4186 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2001 | 4462 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 5867 | 0.080 |
Why?
|
| Hypertension | 6 | 2011 | 8480 | 0.080 |
Why?
|
| Models, Statistical | 2 | 2019 | 5102 | 0.080 |
Why?
|
| Arginine | 2 | 2011 | 944 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3086 | 0.080 |
Why?
|
| Thiazoles | 1 | 2015 | 1483 | 0.080 |
Why?
|
| Multigene Family | 2 | 2004 | 1102 | 0.070 |
Why?
|
| Luciferases | 1 | 2009 | 733 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1994 | 1801 | 0.070 |
Why?
|
| Prevalence | 3 | 2019 | 15226 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2000 | 4042 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 7913 | 0.070 |
Why?
|
| Osteochondritis | 1 | 2006 | 23 | 0.070 |
Why?
|
| Islets of Langerhans | 2 | 2022 | 1352 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2001 | 802 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10481 | 0.070 |
Why?
|
| Glucose Tolerance Test | 3 | 2019 | 1150 | 0.070 |
Why?
|
| Logistic Models | 5 | 2015 | 13408 | 0.070 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2006 | 22 | 0.070 |
Why?
|
| Adolescent | 13 | 2013 | 85781 | 0.070 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 15076 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2503 | 0.070 |
Why?
|
| Chromosomes, Human | 2 | 2001 | 457 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2008 | 404 | 0.070 |
Why?
|
| Cathepsins | 1 | 2007 | 241 | 0.070 |
Why?
|
| United States | 9 | 2023 | 69872 | 0.070 |
Why?
|
| Paired Box Transcription Factors | 1 | 2007 | 215 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2012 | 35421 | 0.070 |
Why?
|
| Awards and Prizes | 1 | 2010 | 375 | 0.070 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 517 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 776 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3752 | 0.060 |
Why?
|
| Patient Selection | 1 | 2017 | 4215 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 563 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2009 | 5179 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2007 | 359 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 360 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4554 | 0.060 |
Why?
|
| Cause of Death | 1 | 2015 | 3584 | 0.060 |
Why?
|
| Autoimmunity | 2 | 2019 | 1349 | 0.060 |
Why?
|
| Child | 11 | 2012 | 77709 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2012 | 4456 | 0.060 |
Why?
|
| Proteomics | 3 | 2022 | 3638 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2009 | 1116 | 0.060 |
Why?
|
| Radiography | 3 | 2008 | 7023 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9959 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1970 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2005 | 526 | 0.060 |
Why?
|
| Family | 4 | 2012 | 3147 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 1085 | 0.060 |
Why?
|
| Mice, Knockout | 5 | 2019 | 14557 | 0.060 |
Why?
|
| Proteinuria | 5 | 2015 | 658 | 0.060 |
Why?
|
| Mortality | 1 | 2014 | 2864 | 0.060 |
Why?
|
| DNA Probes | 2 | 1994 | 560 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2012 | 41006 | 0.050 |
Why?
|
| Genetics, Population | 1 | 2008 | 934 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2007 | 6365 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 2005 | 610 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2006 | 1654 | 0.050 |
Why?
|
| Algorithms | 2 | 2021 | 13881 | 0.050 |
Why?
|
| Brazil | 2 | 2019 | 1270 | 0.050 |
Why?
|
| Body Height | 1 | 2008 | 1577 | 0.050 |
Why?
|
| Hydroxybutyrates | 4 | 1990 | 82 | 0.050 |
Why?
|
| Mast Cells | 1 | 2009 | 1544 | 0.050 |
Why?
|
| Endostatins | 1 | 2022 | 174 | 0.050 |
Why?
|
| HLA Antigens | 2 | 2019 | 1381 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 7 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 9438 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2022 | 16689 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1117 | 0.050 |
Why?
|
| Antiporters | 2 | 1992 | 277 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2002 | 328 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 252 | 0.050 |
Why?
|
| Collagen | 2 | 2002 | 2689 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3772 | 0.050 |
Why?
|
| RNA Interference | 1 | 2009 | 2889 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2019 | 21827 | 0.050 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1999 | 19 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 1999 | 10 | 0.050 |
Why?
|
| DNA Primers | 2 | 2002 | 2892 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2014 | 11727 | 0.040 |
Why?
|
| Cross-Sectional Studies | 7 | 2013 | 25043 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2001 | 434 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2020 | 235 | 0.040 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 1791 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2001 | 394 | 0.040 |
Why?
|
| Rickets | 1 | 1999 | 74 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2001 | 396 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2022 | 588 | 0.040 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 12072 | 0.040 |
Why?
|
| Mice | 9 | 2022 | 81183 | 0.040 |
Why?
|
| Young Adult | 6 | 2021 | 56430 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2013 | 6171 | 0.040 |
Why?
|
| Heterozygote | 2 | 2002 | 2804 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2001 | 1114 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2020 | 63114 | 0.040 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 1997 | 67 | 0.040 |
Why?
|
| Leptin | 1 | 2006 | 1599 | 0.040 |
Why?
|
| Friedreich Ataxia | 1 | 1998 | 76 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2009 | 2899 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2021 | 12245 | 0.040 |
Why?
|
| Growth Plate | 1 | 1999 | 274 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2421 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2000 | 981 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1998 | 261 | 0.040 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 1997 | 152 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2022 | 1549 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2005 | 1809 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 19905 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2019 | 595 | 0.040 |
Why?
|
| Minority Groups | 1 | 2004 | 1223 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2000 | 1005 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2015 | 19229 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1999 | 2050 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2022 | 6622 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 15540 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 1157 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 57776 | 0.030 |
Why?
|
| Glucokinase | 1 | 1996 | 103 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2022 | 964 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2022 | 852 | 0.030 |
Why?
|
| Body Weight | 3 | 2007 | 4669 | 0.030 |
Why?
|
| Models, Animal | 1 | 2022 | 2171 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1996 | 375 | 0.030 |
Why?
|
| DNA-Cytosine Methylases | 1 | 1994 | 17 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2029 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2023 | 39050 | 0.030 |
Why?
|
| Time Factors | 5 | 2019 | 40075 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1996 | 271 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2001 | 1053 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 2007 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1994 | 111 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 316 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2508 | 0.030 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2886 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2006 | 3279 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 803 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 873 | 0.030 |
Why?
|
| Longevity | 1 | 2021 | 1070 | 0.030 |
Why?
|
| Renal Circulation | 3 | 1989 | 333 | 0.030 |
Why?
|
| Basal Metabolism | 1 | 2015 | 168 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2020 | 13815 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2015 | 2016 | 0.030 |
Why?
|
| Adipocytes | 2 | 2013 | 1184 | 0.030 |
Why?
|
| Lactates | 3 | 1990 | 432 | 0.030 |
Why?
|
| Sterol Esterase | 1 | 2013 | 37 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1994 | 708 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2019 | 2373 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 1419 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1994 | 1375 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 198 | 0.030 |
Why?
|
| Factor IX | 1 | 2012 | 77 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Genes, ras | 1 | 1995 | 690 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 970 | 0.030 |
Why?
|
| Cholesterol | 2 | 1999 | 2917 | 0.030 |
Why?
|
| C-Peptide | 2 | 2010 | 419 | 0.030 |
Why?
|
| Arthrography | 1 | 2012 | 149 | 0.020 |
Why?
|
| Hemoglobins | 1 | 1997 | 1534 | 0.020 |
Why?
|
| Podocytes | 1 | 2015 | 396 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2001 | 5078 | 0.020 |
Why?
|
| Protein Binding | 2 | 2017 | 9386 | 0.020 |
Why?
|
| ras Proteins | 1 | 1996 | 1060 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1572 | 0.020 |
Why?
|
| Numismatics | 1 | 2010 | 17 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 1996 | 817 | 0.020 |
Why?
|
| Apolipoproteins | 1 | 1993 | 317 | 0.020 |
Why?
|
| Polymers | 1 | 1998 | 1621 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 2035 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 1889 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2010 | 210 | 0.020 |
Why?
|
| Factor VIII | 1 | 2012 | 347 | 0.020 |
Why?
|
| Immune System | 1 | 2015 | 805 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 95 | 0.020 |
Why?
|
| Trans-Activators | 1 | 1999 | 2924 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 3508 | 0.020 |
Why?
|
| Syndrome | 1 | 1996 | 3251 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3597 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 29144 | 0.020 |
Why?
|
| Gene Expression | 2 | 2008 | 7799 | 0.020 |
Why?
|
| Health Behavior | 1 | 2021 | 2636 | 0.020 |
Why?
|
| Prostaglandins | 1 | 1990 | 405 | 0.020 |
Why?
|
| Fibronectins | 2 | 2007 | 726 | 0.020 |
Why?
|
| 3-Hydroxybutyric Acid | 4 | 1990 | 87 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1995 | 1782 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29063 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 645 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1999 | 2575 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2649 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 300 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2009 | 144 | 0.020 |
Why?
|
| Kinetics | 6 | 1992 | 6473 | 0.020 |
Why?
|
| Contrast Media | 1 | 2001 | 5300 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2969 | 0.020 |
Why?
|
| Glucagon | 1 | 1990 | 533 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1993 | 878 | 0.020 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2013 | 967 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2007 | 75 | 0.020 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1989 | 393 | 0.020 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 1987 | 86 | 0.020 |
Why?
|
| Computational Biology | 2 | 2011 | 3521 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2971 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2187 | 0.020 |
Why?
|
| Models, Biological | 3 | 2020 | 9583 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2007 | 335 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1989 | 488 | 0.020 |
Why?
|
| Biological Transport | 1 | 1991 | 2118 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 130 | 0.020 |
Why?
|
| Epoxy Compounds | 1 | 2007 | 136 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1989 | 625 | 0.020 |
Why?
|
| Meat | 1 | 1990 | 592 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3339 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 513 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2007 | 424 | 0.020 |
Why?
|
| Thailand | 1 | 2007 | 296 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 1007 | 0.020 |
Why?
|
| Dietary Proteins | 2 | 1990 | 963 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4217 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6234 | 0.020 |
Why?
|
| Acetates | 1 | 1987 | 311 | 0.020 |
Why?
|
| Sample Size | 1 | 2009 | 845 | 0.020 |
Why?
|
| Acyltransferases | 1 | 1987 | 294 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1992 | 2455 | 0.020 |
Why?
|
| Glucose Clamp Technique | 3 | 1992 | 266 | 0.020 |
Why?
|
| Hypoglycemia | 2 | 1990 | 861 | 0.020 |
Why?
|
| Fetal Hemoglobin | 1 | 2008 | 341 | 0.020 |
Why?
|
| Diet | 1 | 2023 | 7939 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2007 | 390 | 0.020 |
Why?
|
| Infant | 3 | 2002 | 35136 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 2017 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 209 | 0.020 |
Why?
|
| Neck | 1 | 2009 | 697 | 0.020 |
Why?
|
| Elbow Joint | 1 | 2008 | 357 | 0.020 |
Why?
|
| Insulinoma | 1 | 2005 | 124 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 2008 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2009 | 1344 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2007 | 493 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 2994 | 0.020 |
Why?
|
| North America | 1 | 2007 | 1249 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 1375 | 0.010 |
Why?
|
| Age Factors | 2 | 2012 | 18370 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6756 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2013 | 6459 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1240 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 1364 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 2839 | 0.010 |
Why?
|
| Eating | 1 | 1990 | 1536 | 0.010 |
Why?
|
| P-Selectin | 1 | 2005 | 600 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 625 | 0.010 |
Why?
|
| Thrombin | 1 | 2005 | 598 | 0.010 |
Why?
|
| Temperature | 1 | 2009 | 2206 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2356 | 0.010 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 896 | 0.010 |
Why?
|
| CHO Cells | 1 | 2005 | 1406 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5952 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1992 | 5021 | 0.010 |
Why?
|
| Smoking | 2 | 2012 | 8987 | 0.010 |
Why?
|
| Point Mutation | 1 | 2007 | 1623 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13033 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2013 | 4577 | 0.010 |
Why?
|
| Platelet Activation | 1 | 2005 | 673 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 2472 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 893 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 2005 | 550 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2001 | 25625 | 0.010 |
Why?
|
| Human Genome Project | 1 | 2001 | 193 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5892 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.010 |
Why?
|
| Fathers | 1 | 2002 | 358 | 0.010 |
Why?
|
| Liver | 1 | 2015 | 7474 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2008 | 2309 | 0.010 |
Why?
|
| Adiposity | 1 | 2009 | 1807 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 2645 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3920 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 871 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1999 | 169 | 0.010 |
Why?
|
| Epiphyses | 1 | 1999 | 189 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2009 | 2585 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
| Response Elements | 1 | 1999 | 312 | 0.010 |
Why?
|
| Fasting | 1 | 2004 | 1593 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 834 | 0.010 |
Why?
|
| Hemodynamics | 4 | 1990 | 4199 | 0.010 |
Why?
|
| Fractures, Spontaneous | 1 | 1999 | 230 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12788 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 8436 | 0.010 |
Why?
|
| Hormones | 2 | 1992 | 889 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
| Exercise Test | 1 | 2004 | 2074 | 0.010 |
Why?
|
| Heart | 1 | 1990 | 4467 | 0.010 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1996 | 103 | 0.010 |
Why?
|
| Germany | 1 | 1998 | 862 | 0.010 |
Why?
|
| Exercise | 1 | 2012 | 5615 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1995 | 93 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 1999 | 376 | 0.010 |
Why?
|
| Amiloride | 1 | 1995 | 121 | 0.010 |
Why?
|
| Pyridines | 1 | 2007 | 2825 | 0.010 |
Why?
|
| Life Style | 1 | 2007 | 3835 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 11366 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Insurance, Health | 1 | 2007 | 2494 | 0.010 |
Why?
|
| Health Policy | 1 | 2007 | 2661 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1995 | 554 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1995 | 433 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 5391 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15997 | 0.010 |
Why?
|
| Codon | 1 | 1996 | 611 | 0.010 |
Why?
|
| Cholesterol, VLDL | 1 | 1993 | 65 | 0.010 |
Why?
|
| Femur | 1 | 1999 | 1297 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14722 | 0.010 |
Why?
|
| Genes | 1 | 1996 | 1893 | 0.010 |
Why?
|
| Osteogenesis | 1 | 1999 | 1299 | 0.010 |
Why?
|
| Diuretics | 1 | 1995 | 592 | 0.010 |
Why?
|
| Mothers | 1 | 2002 | 2165 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1993 | 201 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 7880 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6314 | 0.010 |
Why?
|
| Ion Transport | 1 | 1992 | 320 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1992 | 683 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 3966 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2004 | 6442 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 4320 | 0.010 |
Why?
|
| Pyruvates | 1 | 1990 | 87 | 0.010 |
Why?
|
| Dipyridamole | 1 | 1990 | 145 | 0.010 |
Why?
|
| Forearm | 1 | 1992 | 409 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11483 | 0.010 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1989 | 70 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1992 | 620 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 1993 | 640 | 0.010 |
Why?
|
| Indomethacin | 1 | 1990 | 332 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1990 | 467 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1992 | 596 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 1993 | 638 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1989 | 919 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1990 | 406 | 0.000 |
Why?
|
| Acetic Acid | 1 | 1987 | 55 | 0.000 |
Why?
|
| Biological Availability | 1 | 1988 | 397 | 0.000 |
Why?
|
| Cell Division | 1 | 1995 | 4568 | 0.000 |
Why?
|
| Hydrochloric Acid | 1 | 1987 | 76 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 10180 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 2005 | 5256 | 0.000 |
Why?
|
| Metabolic Clearance Rate | 1 | 1987 | 380 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1990 | 695 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1988 | 666 | 0.000 |
Why?
|
| Insulin Infusion Systems | 1 | 1988 | 212 | 0.000 |
Why?
|
| beta 2-Microglobulin | 1 | 1987 | 315 | 0.000 |
Why?
|
| Aging | 1 | 2005 | 8664 | 0.000 |
Why?
|
| Bicarbonates | 1 | 1987 | 313 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 3912 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 77449 | 0.000 |
Why?
|
| Amino Acids | 1 | 1989 | 1736 | 0.000 |
Why?
|
| Brain | 1 | 1990 | 26385 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1987 | 1133 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1987 | 2557 | 0.000 |
Why?
|
| Heart Rate | 1 | 1990 | 4091 | 0.000 |
Why?
|
| Swine | 1 | 1988 | 5917 | 0.000 |
Why?
|
| Echocardiography | 1 | 1990 | 5102 | 0.000 |
Why?
|